Susan E. Hassig
Tulane University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Susan E. Hassig.
The New England Journal of Medicine | 1989
Robert W. Ryder; Wato Nsa; Susan E. Hassig; Frieda Behets; Mark Rayfield; Bayende Ekungola; Ann Marie Nelson; Utshudi Mulenda; Henry Francis; Kashamuka Mwandagalirwa; Farzin Davachi; Martha F. Rogers; Nzila Nzilambi; Alan E. Greenberg; Jonathan M. Mann; Thomas C. Quinn; Peter Piot; James W. Curran
To examine perinatal transmission of the human immunodeficiency virus type 1 (HIV-1) in Zaire, we screened 8108 women who gave birth at one of two Kinshasa hospitals that serve populations of markedly different socioeconomic status. For up to one year, we followed the 475 infants of the 466 seropositive women (5.8 percent of those screened) and the 616 infants of 606 seronegative women matched for age, parity, and hospital. On the basis of clinical criteria, 85 of the seropositive women (18 percent) had the acquired immunodeficiency syndrome (AIDS). The infants of seropositive mothers, as compared with those of seronegative mothers, were more frequently premature, had lower birth weights, and had a higher death rate in the first 28 days (6.2 vs. 1.2 percent; P less than 0.0001). The patterns were similar at the two hospitals. Twenty-one percent of the cultures for HIV-1 of 92 randomly selected cord-blood samples from infants of seropositive women were positive. T4-cell counts were performed in 37 seropositive women, and cord blood from their infants was cultured. The cultures were positive in the infants of 6 of the 18 women with antepartum T4 counts of 400 or fewer cells per cubic millimeter, as compared with none of the infants of the 19 women with more than 400 T4 cells per cubic millimeter (P = 0.02). One year later, 21 percent of the infants of the seropositive mothers had died as compared with 3.8 percent of the control infants (P less than 0.001), and 7.9 percent of their surviving infants had AIDS. We conclude that the mortality rates among children of seropositive mothers are high regardless of socioeconomic status, and that perinatal transmission of HIV-1 has a major adverse effect on infant survival in Kinshasa.
The New England Journal of Medicine | 1991
Alan E. Greenberg; Wato Nsa; Robert W. Ryder; Mvula Medi; Matadi Nzeza; Nsimba Kitadi; Matela Baangi; Nsuami Malanda; Farzin Davachi; Susan E. Hassig
BACKGROUND It is uncertain whether Plasmodium falciparum malaria is more frequent or more severe in children with perinatally acquired human immunodeficiency virus type 1 (HIV-1) infection and whether P. falciparum infection accelerates the progression of HIV-related disease. METHODS We conducted a prospective, longitudinal cohort study in Kinshasa, Zaire. Two hundred sixty children 5 to 9 months of age who had been born to HIV-1-seropositive mothers and 327 children of the same age who had been born to seronegative mothers were monitored intensively for malaria over a 13-month period. All episodes of fever were evaluated with blood smears for malaria, and children found to be infected with P. falciparum were treated with a standard regimen of oral quinine. RESULTS A total of 2899 fevers were evaluated, with 271 cases of malaria identified. No statistically significant differences were found in the incidence, severity, or response to therapy of malaria among four well-defined groups of children: those with the acquired immunodeficiency syndrome (AIDS), those who were HIV-1-seropositive throughout the study, those who were born to HIV-1-seropositive mothers but reverted to seronegative, and those who were seronegative throughout the study. During the 13-month period the incidence of malaria in the 36 children with HIV infection in whom AIDS developed was lower, although not significantly so, than in the 37 in whom AIDS did not. CONCLUSIONS In this study malaria was not more frequent or more severe in children with progressive HIV-1 infection and malaria did not appear to accelerate the rate of progression of HIV-1 disease.
American Journal of Public Health | 1991
Jane T. Bertrand; Bakutuvwidi Makani; Susan E. Hassig; Kinavwidi Lewu Niwembo; Balowa Djunghu; Mbadu Muanda; Chirwisa Chirhamolekwa
This study was conducted in 1988 among a random sample of 6,625 men and women of reproductive age in all 24 administrative zones of Kinshasa, the capital city of Zaire, to determine existing levels of knowledge regarding AIDS (acquired immunodeficiency syndrome), sexual behavior, knowledge and use of condoms in marital and extramarital relations; perceived risk of AIDS, and attitudes toward testing for the human immunodeficiency virus (HIV). Awareness of AIDS is almost universal, and the vast majority know the four main modes of transmission. Almost half believed in transmission by mosquitoes and in a vaccine or cure for AIDS. The majority of male respondents knew of condoms, but negative attitudes toward condom use are widespread, and few respondents perceived them to play a central role in combatting AIDS.
Diabetes Care | 2011
Quoc Manh Nguyen; Jihua Xu; Wei Chen; Susan E. Hassig; Janet C. Rice; Gerald S. Berenson
OBJECTIVE Elevations in alanine aminotransferase (ALT) and γ-glutamyl transferase (GGT), surrogate markers of liver dysfunction and nonalcoholic fatty liver, are considered as part of metabolic syndrome and related type 2 diabetes. However, information is limited regarding the long-term predictability of ALT and GGT in the development of prediabetes and type 2 diabetes. RESEARCH DESIGN AND METHODS In this retrospective cohort study, normoglycemic (n = 874), prediabetic (n = 101), and diabetic (n = 80) adults aged 26–50 years (average age 41.3 years) were followed over an average period of 16 years since their young adulthood (aged 18–38 years, average age 25.1 years), with measurements of cardiometabolic risk factor variables including ALT and GGT. RESULTS The follow-up prevalence rate of adult diabetes status by quartiles of baseline ALT and GGT levels showed an adverse trend for both prediabetes (P < 0.05) and diabetes (P < 0.01). In a longitudinal multivariate logistic regression analysis that included anthropometric, hemodynamic, and metabolic variables, as well as alcohol consumption and smoking, individuals with elevated baseline ALT and GGT levels (per 1-SD increment) were 1.16 and 1.20 times, respectively, more likely to develop diabetes (P = 0.05 for ALT and P < 0.01 for GGT); no such associations were noted for prediabetes. Regarding the predictive value of ALT and GGT, the area under the receiver operating curve analysis yielded C values ranging from 0.70 to 0.82, with values significantly higher for diabetes compared with prediabetes. CONCLUSIONS These findings in younger adults suggest potential clinical utility of including ALT and GGT as biomarkers in diabetes risk assessment formulations.
AIDS | 1990
Susan E. Hassig; Jos Perriens; Ekungola Baende; Mbindule Kahotwa; Kagoyire Bishagara; Nanlele Kinkela; Bila Kapita
In a prospective study of adult admissions to the Department of Internal Medicine at Mama Yemo Hospital, Kinshasa, Zaire in late 1988, 129 women and 122 men were screened for HIV infection. Fifty per cent were found to be seropositive, with half of the seropositives meeting the World Health Organization (WHO) clinical AIDS definition. The HIV seropositives had a mortality rate of 50%, which was significantly higher (P = 0.004) than the 30% mortality rate seen in the seronegative group. Direct costs during hospitalization did not differ (
AIDS | 1988
Robert W. Ryder; Susan E. Hassig
60.30 for HIV seropositives,
Journal of Epidemiology and Community Health | 2009
Fawaz Mzayek; Roger Sherwin; Janet M. Hughes; Susan E. Hassig; Wei Chen; Gerald S. Berenson
56.50 for HIV seronegatives), but pre-hospitalization expenses were significantly higher in the HIV-seropositive group (
Epidemiology | 2004
Stephanie Posner; Leann Myers; Susan E. Hassig; Janet C. Rice; Patricia Kissinger; Thomas A. Farley
170 for HIV seropositives,
AIDS | 1991
Ann Marie Nelson; Susan E. Hassig; Mukende Kayembe; Longengo Okonda; Kabeya Mulanga; Christopher Brown; Kalembayi Kayembe; Mbowa M. Kalengayi; Florabel G. Mullick
110 for HIV seronegatives). Years of productive life lost due to death were also significantly higher for HIV seropositives versus HIV seronegatives (30.6 versus 21.3 years; P = 0.0007), and 73% of the premature mortality in the study population was attributable to HIV infection.
AIDS | 1990
Susan E. Hassig; Nanlele Kinkela; Wato Nsa; Munkolenkole Kamenga; Mibandumba Ndilu; Henry Francis; Robert W. Ryder
The range of issues in the epidemiology of perinatal infection with HIV covers prevalence of HIV in women, types of HIV transmission to the fetus and newborn, problems with testing for HIV infections in neonates, variations in effectiveness of transmission to infants, maternal, fetal and perinatal mortality. In the U.S. 75% of all pediatric AIDS cases are traceable to HIV-positive mothers, but numbers are small. In Central Africa, seroprevalence in women is about 5%, and perinatal HIV is significant. HIV has been demonstrated in fetal tissues and cord blood, indicating transmission in utero. Transmission at birth has not yet been documented. Transmission of HIV after birth, presumably via breastfeeding, has been shown in at least 8 cases. No information is available on HIV titers in breast milk. Diagnosis of HIV infection in newborns is problematic. Cord blood cultures, the p24 antigen test, and the in situ hybridization method are feasible but impractical in most clinics. The Western blot test for IgM-specific antibodies is not specific or sensitive enough for infants. A new method called [DNA] polymerase chain reaction (PCR) is capable of detecting acquired HIV infection, and may be useful in clinics, since it does not require radionuclides. In 11 studies the incidence of HIV infection in infants of seropositive mothers ranged from 8-65%. There is some indication that the stage of the HIV disease, and possibly socioeconomic status, of the mother affect the transmission of the virus. There is no indication that pregnancy worsens maternal HIV status, although there is a suggestion that mothers may worsen in the postpartum period. Several studies show increased incidence of low birth weight and prematurity, associated with higher infant mortality, in newborns of HIV-positive mothers. No effective programs of screening or counseling women at risk of HIV infection and pregnancy have been reported.